PBH

Prestige Consumer Healthcare Inc. NYSE

Healthcare ·Medical - Distribution ·US · prestigebrands.com

$55.09

After hrs $55.18 -0.24%

Mkt Cap $2.8B

52w Low $51.24 10.1% of range 52w High $89.37

50d MA $61.63 200d MA $63.81

P/E (TTM) 12.8x

EV/EBITDA 14.4x

P/B 1.5x

Debt/Equity 0.6x

ROE 10.9%

P/FCF 17.6x

RSI (14) —

ATR (14) —

Beta 0.47

50d MA $61.63

200d MA $63.81

Avg Volume 484.4K

About

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointment…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 5, 2026	AMC	1.16	1.14	-1.7%	65.55	+0.2%	+1.2%	-0.3%	+0.9%	+0.6%	+2.2%	+1.0%	—
Nov 6, 2025	AMC	0.97	1.07	+10.3%	61.36	-0.1%	-2.3%	-1.5%	-1.3%	-1.4%	-2.2%	-1.7%	—
Aug 7, 2025	AMC	1.01	0.95	-5.9%	67.61	-0.4%	-3.0%	-5.5%	-3.4%	-1.7%	-4.5%	-2.7%	—
May 8, 2025	AMC	1.30	1.32	+1.5%	87.04	-1.1%	+0.3%	+1.1%	-0.1%	-1.9%	+0.1%	-1.6%	—
Feb 6, 2025	AMC	1.16	1.22	+5.2%	87.35	-0.2%	-0.4%	-0.2%	-1.6%	-3.6%	-1.9%	-0.6%	—
Nov 7, 2024	AMC	1.08	1.09	+0.9%	80.09	+0.4%	+0.3%	+2.1%	+1.9%	+2.8%	+3.4%	+4.0%	—
Aug 8, 2024	AMC	0.86	0.90	+4.7%	66.84	+0.2%	-0.9%	-2.4%	+0.7%	+1.0%	+2.8%	+8.7%	—
May 14, 2024	AMC	1.14	0.98	-14.0%	71.47	-10.7%	-7.0%	-9.1%	-9.5%	-9.5%	-9.0%	-9.3%	—
Feb 8, 2024	AMC	1.04	1.06	+1.9%	68.80	+0.3%	-0.2%	-1.2%	-3.3%	-1.6%	-0.0%	+8.4%	—
Nov 2, 2023	AMC	1.07	1.07	+0.0%	59.17	+1.4%	+0.7%	+0.9%	+1.2%	-0.2%	-2.4%	+2.3%	—
Aug 3, 2023	AMC	1.01	1.06	+5.0%	66.52	-1.0%	+1.2%	+2.7%	-3.4%	-2.2%	-3.5%	-14.3%	—
May 4, 2023	AMC	1.04	1.07	+2.9%	62.02	+0.1%	-2.0%	-4.1%	-5.8%	-5.3%	-5.9%	-9.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 2	Jefferies	Maintains	Hold → Hold	—	$64.47	$64.15	-0.5%	+1.5%	-0.1%	+4.0%	+1.7%	+2.9%
Nov 7	Canaccord Genuity	Maintains	Buy → Buy	—	$61.36	$61.28	-0.1%	-2.3%	-1.5%	-1.3%	-1.4%	-2.2%
Oct 27	Jefferies	Maintains	Hold → Hold	—	$62.23	$61.98	-0.4%	+0.3%	-0.3%	-2.4%	-3.1%	-2.6%
Oct 21	Oppenheimer	Maintains	Outperform → Outperform	—	$62.18	$61.78	-0.6%	+0.5%	+1.9%	+0.7%	+0.1%	+0.4%
Aug 8	Canaccord Genuity	Maintains	Buy → Buy	—	$67.61	$67.31	-0.4%	-3.0%	-5.5%	-3.4%	-1.7%	-4.5%
Mar 21	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$84.36	$83.71	-0.8%	-0.2%	+1.2%	+0.8%	+0.8%	+2.0%
Feb 13	Oppenheimer	Maintains	Outperform → Outperform	—	$84.21	$85.44	+1.5%	+1.7%	+2.1%	+1.2%	+0.8%	+0.7%
Feb 7	DA Davidson	Maintains	Buy → Buy	—	$87.35	$87.15	-0.2%	-0.4%	-0.2%	-1.6%	-3.6%	-1.9%
Feb 7	Canaccord Genuity	Maintains	Buy → Buy	—	$87.35	$87.15	-0.2%	-0.4%	-0.2%	-1.6%	-3.6%	-1.9%
Nov 11	DA Davidson	Maintains	Buy → Buy	—	$80.37	$81.43	+1.3%	+1.7%	+1.6%	+2.4%	+3.0%	+2.5%
Aug 28	DA Davidson	Maintains	Buy → Buy	—	$72.61	$72.73	+0.2%	+1.5%	+1.9%	+2.8%	+2.0%	+4.0%
Aug 9	Canaccord Genuity	Maintains	Buy → Buy	—	$66.84	$66.97	+0.2%	-0.9%	-2.4%	+0.7%	+1.0%	+2.8%
Aug 9	DA Davidson	Maintains	Buy → Buy	—	$66.84	$66.97	+0.2%	-0.9%	-2.4%	+0.7%	+1.0%	+2.8%
Jun 21	DA Davidson	Upgrade	Neutral → Buy	—	$65.28	$66.61	+2.0%	+6.3%	+4.9%	+5.9%	+5.5%	+6.6%
May 21	Canaccord Genuity	Maintains	Buy → Buy	—	$64.70	$64.70	+0.0%	+0.5%	+0.0%	-1.3%	-1.1%	-2.3%
May 16	DA Davidson	Maintains	Neutral → Neutral	—	$66.46	$66.11	-0.5%	-2.2%	-2.7%	-2.6%	-2.1%	-2.6%
Jun 26	DA Davidson	Maintains	Neutral → Neutral	—	$57.21	$57.17	-0.1%	+1.2%	+1.6%	+1.2%	+3.1%	+3.9%
May 8	DA Davidson	Maintains	Neutral → Neutral	—	$60.76	$60.61	-0.2%	-2.1%	-3.9%	-3.4%	-4.0%	-2.9%
Mar 17	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$61.78	$61.51	-0.4%	-0.8%	-0.3%	-0.7%	-1.3%	-1.3%
Feb 17	Oppenheimer	Maintains	Outperform → Outperform	—	$60.76	$61.41	+1.1%	+1.2%	+0.6%	+0.1%	+1.7%	+0.2%
Jan 13	Oppenheimer	Maintains	Outperform → Outperform	—	$65.77	$66.85	+1.6%	+1.3%	+0.1%	+0.1%	+1.1%	+1.4%
Nov 17	Canaccord Genuity	Maintains	Buy → Buy	—	$58.35	$58.58	+0.4%	+0.2%	+2.4%	+2.1%	+4.4%	+2.5%
May 10	Jefferies	Upgrade	Hold → Buy	—	$57.45	$58.68	+2.1%	+0.2%	-3.2%	-2.0%	-1.2%	-0.8%
May 9	DA Davidson	Maintains	Neutral → Neutral	—	$54.88	$55.16	+0.5%	+4.7%	+4.9%	+1.4%	+2.6%	+3.5%
May 9	Oppenheimer	Upgrade	Perform → Outperform	—	$54.88	$55.16	+0.5%	+4.7%	+4.9%	+1.4%	+2.6%	+3.5%
Nov 15	DA Davidson	Maintains	Neutral → Neutral	—	$62.74	$62.74	+0.0%	-2.3%	-2.2%	-2.8%	-4.0%	-7.1%
Aug 6	DA Davidson	Maintains	Neutral → Neutral	—	$56.47	$57.00	+0.9%	+4.1%	+3.4%	+5.7%	+7.2%	+5.2%
May 28	DA Davidson	Maintains	Neutral → Neutral	—	$50.30	$50.72	+0.8%	-0.9%	-0.7%	-0.7%	+0.1%	-0.6%
May 10	DA Davidson	Maintains	Neutral → Neutral	—	$46.10	$46.75	+1.4%	+1.6%	+2.2%	+1.1%	+5.4%	+5.2%
Nov 6	DA Davidson	Maintains	Neutral → Neutral	—	$33.68	$33.70	+0.1%	-1.9%	+1.2%	+4.8%	+4.6%	+4.6%
Aug 7	DA Davidson	Downgrade	Buy → Neutral	—	$40.79	$39.81	-2.4%	-2.1%	-3.0%	-6.4%	-7.4%	-7.5%
Mar 26	Jefferies	Upgrade	Hold → Buy	—	$30.74	$33.00	+7.4%	+14.3%	+18.4%	+20.9%	+19.3%	+20.8%
Mar 24	Oppenheimer	Maintains	Perform → Perform	—	$29.50	$30.98	+5.0%	+9.7%	+4.2%	+19.2%	+23.4%	+26.0%
Mar 19	DA Davidson	Upgrade	Neutral → Buy	—	$30.00	$30.60	+2.0%	+4.4%	+0.6%	-1.7%	+7.8%	+2.5%
Nov 4	DA Davidson	Maintains	Neutral → Neutral	—	$36.93	$37.41	+1.3%	+3.7%	+2.5%	+1.8%	+3.1%	+3.5%
Jan 15	Raymond James	Downgrade	Outperform → Market Perform	—	$28.53	$26.36	-7.6%	-1.5%	+0.4%	-0.6%	-2.3%	-3.6%
May 5	B. Riley FBR	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
Feb 5	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$35.83	$35.50	-0.9%	-0.8%	+4.0%	+3.0%	-1.3%	-5.8%
Feb 5	KeyBanc	Maintains	Overweight → Overweight	—	$35.83	$35.50	-0.9%	-0.8%	+4.0%	+3.0%	-1.3%	-5.8%
Feb 5	DA Davidson	Downgrade	Buy → Neutral	—	$35.83	$35.50	-0.9%	-0.8%	+4.0%	+3.0%	-1.3%	-5.8%
Dec 4	William Blair	Upgrade	Market Perform → Outperform	—	$44.56	$46.79	+5.0%	+7.0%	+5.0%	+5.2%	+4.3%	+4.9%
Nov 15	BMO Capital	Upgrade	Market Perform → Outperform	—	$40.67	$40.70	+0.1%	+0.0%	+2.5%	+4.0%	+4.7%	+5.1%
Nov 3	Jefferies	Maintains	Hold → Hold	—	$43.76	$43.50	-0.6%	-1.8%	-1.6%	-2.9%	-5.1%	-6.3%
May 22	Raymond James	Upgrade	Market Perform → Outperform	—	$49.39	$51.66	+4.6%	+1.6%	+1.2%	+1.2%	+1.6%	+0.9%
May 9	DA Davidson	Maintains	Buy → Buy	—	$56.11	$56.80	+1.2%	+2.0%	+1.5%	-4.6%	-6.9%	-8.7%
Nov 17	Gabelli & Co.	Maintains	Buy → Buy	—	$49.83	$50.67	+1.7%	+1.0%	-1.4%	-1.6%	-1.7%	-1.6%
Mar 7	KeyBanc	Maintains	Overweight → Overweight	—	$51.28	$51.08	-0.4%	+0.8%	+0.1%	+0.8%	+0.5%	+3.2%
Feb 5	PiperJaffray	Maintains	Overweight → Overweight	—	$49.25	$49.80	+1.1%	-2.4%	-1.3%	-1.0%	-3.3%	-4.7%
Jan 25	Jefferies	Maintains	Underperform → Underperform	—	$47.26	$46.95	-0.7%	-1.8%	-1.0%	-1.4%	-3.4%	-1.2%
Nov 30	Jefferies	Downgrade	Hold → Underperform	—	$54.19	$53.79	-0.7%	-6.1%	-3.1%	-1.9%	-5.0%	-3.8%

Recent Filings

8-K · 1.01 !! High

Unknown — 8-K 1.01: Material Agreement

Prestige Consumer Healthcare's new agreement with Foundation Consumer Brands could expand distribution channels or enable product line extensions, potentially driving revenue growth and improving competitive positioning in the consumer health sector.

Mar 20

8-K · 7.01 ! Medium

Prestige Consumer Healthcare Inc. -- 8-K 7.01: Regulation FD Disclosure

Prestige Consumer Healthcare (PBH) disclosed Q4 2025 earnings presentation materials to investors, indicating management expects to use these slides in upcoming investor communications and analyst meetings.

Feb 5

Data updated apr 26, 2026 6:49pm · Source: massive.com